Keratoconus Clinical Presentation

  • Author: Barry A Weissman, OD, PhD, FAAO; Chief Editor: Hampton Roy Sr, MD   more...
 
Updated: Nov 23, 2011
 

History

Patients with keratoconus (KC) often report decreasing vision (distortions, glare/flare, and monocular diplopia or ghost images), with multiple unsatisfactory attempts in obtaining optimum spectacle correction.

Soft contact lenses (CLs) and spectacles may initially give satisfactory vision, but vision tends to decline over time and requires rigid gas permeable (GP) contact lenses for correction. Other contact lens options include piggyback lens systems (usually a GP lens over a soft, perhaps silicone hydrogel, lens), hybrid lenses (eg, Sofperm TM, Synergeyes TM), and GP scleral lenses.[9, 15, 12, 10, 22]

Next

Physical

Keratoconus is divided into mild, moderate, and advanced.

  • Mild keratoconus
    • External and corneal signs are often absent or minimal.
    • A history of multiple inadequate spectacle corrections of one or both eyes may be noted and may include oblique astigmatism on refraction as well as moderate-to-high myopia.
    • Irregularly astigmatic keratometry values (egg-shaped), not necessarily on the steep side of normal (approximately 45 diopters [D]), are consistent with diagnosis.
    • Diagnosis can be confirmed with computer-assisted videokeratography, which may reveal corneal inferior steepening (approximately 80% of keratoconus cases), central corneal astigmatic steepening (approximately 15% of keratoconus cases), or even bilateral temporal steepening (extremely rare).
    • Diagnosis may also be aided by applying a diagnostic rigid contact lens with its base curve equal to the flat keratometry value. One observes a typical nipple pattern by use of sodium fluorescein dye in the underlying tear film.
  • Moderate keratoconus[12]
    • One or more corneal signs of keratoconus are often present.
      • Enhanced appearance of the corneal nerves is noted.
      • Approximately 40% of eyes in patients with moderate keratoconus develop Vogt striae (fine-stress lines) in the deep stroma.
      • Approximately 50% develop the deposition of iron in the basal epithelial cells in a (often partial) ring shape at the base of the conical protrusion called the Fleischer ring.
      • Approximately 20% develop corneal scarring.
    • Superficial corneal scarring can be fibular, nebular, or nodular.
    • Deep stromal scarring may occur, perhaps representing resolved mini-hydrops events.
    • Some patients show scarring at the level of the Descemet membrane (posterior limiting lamina), consistent in appearance with posterior polymorphous corneal dystrophy.
    • Paraxial (usually inferior to the pupil) stromal thinning may be appreciated.
    • Keratometry values typically increase to 45-52 D.
    • Distortion of the retinoscopy and direct ophthalmoscope red pupillary reflex may allow observation of "scissoring" or an inferior distortion termed the oil drop sign.
    • The Munson sign is noted when, upon downgaze, a "V" shape is noted in the cornea's profile against the lower lid margin, an accentuation of the conical shape of the modest to advanced keratoconus cornea.
  • Advanced keratoconus
    • This often results in keratometry values greater than 52 D and enhancement of all corneal signs, symptoms, and visual loss/distortion.
    • Vogt striae are seen in approximately 60% of eyes, and Fleischer ring and/or scarring are seen in approximately 70% of eyes.
    • Acute corneal hydrops can occur.
Previous
Next

Causes

Although not definitively identified, genetic inheritance, systemic and ocular associations, eye rubbing, atopy and specifically ocular allergies, and contact lens wear are proposed risk factors.[23, 9, 10, 11]

Several reports suggest, perhaps coincidentally, associations with keratoconus and other corneal dystrophies.

Previous
 
 
Contributor Information and Disclosures
Author

Barry A Weissman, OD, PhD, FAAO  Chief of Contact Lens Service, Professor, Department of Ophthalmology, Jules Stein Eye Institute, University of California, Los Angeles, David Geffen School of Medicine; Adjunct Professor of Optometry, Southern California College of Optometry

Barry A Weissman, OD, PhD, FAAO is a member of the following medical societies: American Academy of Optometry, American Optometric Association, California Optometric Society, and International Society for Contact Lens Research

Disclosure: VSP None Speaking and teaching; Alcon None Speaking and teaching; Vistakon/The Vision Care Institute Grant/research funds support of Fellowship program

Coauthor(s)

Karen K Yeung, OD, FAAO  Director of Optometry, Arthur Ashe Student Health and Wellness Center, University of California, Los Angeles, David Geffen School of Medicine

Karen K Yeung, OD, FAAO is a member of the following medical societies: American Academy of Optometry

Disclosure: Nothing to disclose.

Specialty Editor Board

Fernando H Murillo-Lopez, MD  Senior Surgeon, Unidad Privada de Oftalmologia CEMES

Fernando H Murillo-Lopez, MD is a member of the following medical societies: American Academy of Ophthalmology

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Christopher J Rapuano, MD  Professor, Department of Ophthalmology, Jefferson Medical College of Thomas Jefferson University; Director of the Cornea Service, Co-Director of Refractive Surgery Department, Wills Eye Institute

Christopher J Rapuano, MD is a member of the following medical societies: American Academy of Ophthalmology, American Society of Cataract and Refractive Surgery, Contact Lens Association of Ophthalmologists, Cornea Society, Eye Bank Association of America, International Society of Refractive Surgery, and Pan-American Association of Ophthalmology

Disclosure: Allergan Honoraria Speaking and teaching; Allergan Consulting fee Consulting; Alcon Honoraria Speaking and teaching; RPS Ownership interest Other; EyeGate Pharma Consulting fee Consulting; Bausch & Lomb Honoraria Speaking and teaching; Bausch & Lomb Consulting; Merck Honoraria Speaking and teaching

Lance L Brown, OD, MD  Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri

Disclosure: Nothing to disclose.

Chief Editor

Hampton Roy Sr, MD  Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences

Hampton Roy Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, and Pan-American Association of Ophthalmology

Disclosure: Nothing to disclose.

References
  1. Gondhowiardjo TD, van Haeringen NJ. Corneal aldehyde dehydrogenase, glutathione reductase, and glutathione S-transferase in pathologic corneas. Cornea. Jul 1993;12(4):310-4. [Medline].

  2. Behndig A, Karlsson K, Johansson BO, Brannstrom T, Marklund SL. Superoxide dismutase isoenzymes in the normal and diseased human cornea. Invest Ophthalmol Vis Sci. Sep 2001;42(10):2293-6. [Medline].

  3. Buddi R, Lin B, Atilano SR, Zorapapel NC, Kenney MC, Brown DJ. Evidence of oxidative stress in human corneal diseases. J Histochem Cytochem. Mar 2002;50(3):341-51. [Medline].

  4. Atilano SR, Coskun P, Chwa M, et al. Accumulation of mitochondrial DNA damage in keratoconus corneas. Invest Ophthalmol Vis Sci. Apr 2005;46(4):1256-63. [Medline].

  5. Kennedy RH, Bourne WM, Dyer JA. A 48-year clinical and epidemiologic study of keratoconus. Am J Ophthalmol. Mar 15 1986;101(3):267-73. [Medline].

  6. Udar N, Atilano SR, Brown DJ, et al. SOD1: a candidate gene for keratoconus. Invest Ophthalmol Vis Sci. Aug 2006;47(8):3345-51. [Medline].

  7. Lema I, Duran JA. Inflammatory molecules in the tears of patients with keratoconus. Ophthalmology. Apr 2005;112(4):654-9. [Medline].

  8. Lema I, Duran JA, Ruiz C, Diez-Feijoo E, Acera A, Merayo J. Inflammatory response to contact lenses in patients with keratoconus compared with myopic subjects. Cornea. Aug 2008;27(7):758-63. [Medline].

  9. Krachmer JH, Feder RS, Belin MW. Keratoconus and related noninflammatory corneal thinning disorders. Surv Ophthalmol. Jan-Feb 1984;28(4):293-322. [Medline].

  10. Rabinowitz YS. Keratoconus. Surv Ophthalmol. Jan-Feb 1998;42(4):297-319. [Medline].

  11. Macsai MS, Varley GA, Krachmer JH. Development of keratoconus after contact lens wear. Patient characteristics. Arch Ophthalmol. Apr 1990;108(4):534-8. [Medline].

  12. Zadnik K, Barr JT, Gordon MO, Edrington TB. Biomicroscopic signs and disease severity in keratoconus. Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study Group. Cornea. Mar 1996;15(2):139-46. [Medline].

  13. Wagner H, Barr JT, Zadnik K. Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study: methods and findings to date. Cont Lens Anterior Eye. Sep 2007;30(4):223-32. [Medline].

  14. Moodaley LC, Woodward EG, Liu CS, Buckley RJ. Life expectancy in keratoconus. Br J Ophthalmol. Oct 1992;76(10):590-1. [Medline].

  15. Lass JH, Lembach RG, Park SB, et al. Clinical management of keratoconus. A multicenter analysis. Ophthalmology. Apr 1990;97(4):433-45. [Medline].

  16. Shimmura S, Tsubota K. Deep anterior lamellar keratoplasty. Curr Opin Ophthalmol. Aug 2006;17(4):349-55. [Medline].

  17. Fontana L, Parente G, Tassinari G. Clinical outcomes after deep anterior lamellar keratoplasty using the big-bubble technique in patients with keratoconus. Am J Ophthalmol. Jan 2007;143(1):117-124. [Medline].

  18. Colin J, Malet FJ. Intacs for the correction of keratoconus: two-year follow-up. J Cataract Refract Surg. Jan 2007;33(1):69-74. [Medline].

  19. Rabinowitz YS. Intacs for keratoconus. Curr Opin Ophthalmol. Jul 2007;18(4):279-83. [Medline].

  20. Riaskup-Wolf F, Hoyer A, Spoerl E, et al. Collagen crosslinking with riboflavin and ultra violet A light in keratoconus: long term results. J of Cataract and Refractive Surgery. 2008;34(5):796-801.

  21. Kymionis GD, Portaliou DM, Kounis GA, et al. Simultaneous Topography-Guided Photorefractive Keratectomy Followed by Corneal Collagen Cross-linking for Keratoconus. Am J Ophthalmol. Nov 2011;152(5):748-55. [Medline].

  22. Visser ES, Visser R, van Lier HJ, Otten HM. Modern scleral lenses part I: clinical features. Eye Contact Lens. Jan 2007;33(1):13-20. [Medline].

  23. Karseras AG, Ruben M. Aetiology of keratoconus. Br J Ophthalmol. Jul 1976;60(7):522-5. [Medline].

  24. Rabinowitz YS, Garbus J, McDonnell PJ. Computer-assisted corneal topography in family members of patients with keratoconus. Arch Ophthalmol. Mar 1990;108(3):365-71. [Medline].

  25. Maeda N, Klyce SD, Smolek MK. Comparison of methods for detecting keratoconus using videokeratography. Arch Ophthalmol. Jul 1995;113(7):870-4. [Medline].

  26. Alio JL, Shabeyek MH. Corneal higher order aberrations: a method to grade keratoconus. Journal of Refractive Surgery. 2006;22(6):539-45.

  27. Jafri B, Li X, Yang H, Rabinowitz YS. Higher order wavefront aberrations and topography in early and suspected keratoconus. J Refract Surg. Oct 2007;23(8):774-81. [Medline].

  28. Kosaki R, Maeda N, Bessho K, Hori Y, Nishida K, Suzaki A. Magnitude and orientation of Zernike terms in patients with keratoconus. Invest Ophthalmol Vis Sci. Jul 2007;48(7):3062-8. [Medline].

  29. Sorbara L, Dalton K. The use of video-keratoscopy in predicting contact lens parameters for keratoconic fitting. Cont Lens Anterior Eye. Feb 1 2010;[Medline].

  30. Weissman BA, Chun MW, Barnhart LA. Corneal abrasion associated with contact lens correction of keratoconus-a retrospective study. Optom Vis Sci. 1994;71(11):677-81.

  31. Spoerl E, Huhle M, Seiler T. Induction of cross-links in corneal tissue. Exp Eye Res. Jan 1998;66(1):97-103. [Medline].

  32. Raiskup F, Spoerl E. Corneal Cross-linking with Hypo-osmolar Riboflavin Solution in Thin Keratoconic Corneas. Am J Ophthalmol. Jul 2011;152(1):28-32.e1. [Medline].

  33. Wollensak G, Iomdina E. Biomechanical and histological changes after corneal crosslinking with and without epithelial debridement. J Cataract Refract Surg. Mar 2009;35(3):540-6. [Medline].

  34. Kelly TL, Williams KA, Coster DJ. Corneal Transplantation for Keratoconus: A Registry Study. Arch Ophthalmol. Jun 2011;129(6):691-697. [Medline].

  35. Kato N, Toda I, Kawakita T, Sakai C, Tsubota K. Topography-guided conductive keratoplasty: treatment for advanced keratoconus. Am J Ophthalmol. Oct 2010;150(4):481-489.e1. [Medline].

  36. Bartlett JD, Howes JF, Ghormley NR, et al. Safety and efficacy of loteprednol etabonate for treatment of papillae in contact lens-associated giant papillary conjunctivitis. Curr Eye Res. Apr 1993;12(4):313-21. [Medline].

  37. [Guideline] American Academy of Ophthalmology Refractive Management/Intervention Panel. Refractive errors & refractive surgery. San Francisco (CA): American Academy of Ophthalmology; 2007.

  38. Chwa M, Atilano SR, Hertzog D, Zheng H, Langberg J, Kim DW. Hypersensitive response to oxidative stress in keratoconus corneal fibroblasts. Invest Ophthalmol Vis Sci. Oct 2008;49(10):4361-9. [Medline].

  39. Kenney MC, Chwa M, Atilano SR, et al. Increased levels of catalase and cathepsin V/L2 but decreased TIMP-1 in keratoconus corneas: evidence that oxidative stress plays a role in this disorder. Invest Ophthalmol Vis Sci. Mar 2005;46(3):823-32. [Medline].

  40. Korb DR, Finnemore VM, Herman JP. Apical changes and scarring in keratoconus as related to contact lens fitting techniques. J Am Optom Assoc. Mar 1982;53(3):199-205. [Medline].

  41. Kymes SM, Walline JJ, Zadnik K, Sterling J, Gordon MO. Changes in the quality-of-life of people with keratoconus. Am J Ophthalmol. Apr 2008;145(4):611-617. [Medline].

  42. Machkiewicz Z, Maatta M, Stenman M, et al. Colagenolytic proteinases in keratoconus. Cornea. 2006;25(5):603-10.

  43. Maguire LJ, Bourne WM. Corneal topography of early keratoconus. Am J Ophthalmol. Aug 15 1989;108(2):107-12. [Medline].

  44. McMahon TT, Edrington TB, Szczotka-Flynn L, et al. Longitudinal changes in corneal curvature in keratoconus. Cornea. Apr 2006;25(3):296-305. [Medline].

  45. Moodaley L, Buckley RJ, Woodward EG. Surgery to improve contact lens wear in keratoconus. CLAO J. Apr 1991;17(2):129-31. [Medline].

  46. Rabinowitz YS. The genetics of keratoconus. Ophthalmol Clin North Am. Dec 2003;16(4):607-20, vii. [Medline].

  47. Sherwin T, Brookes NH. Morphological changes in keratoconus: pathology or pathogenesis. Clin Experiment Ophthalmol. Apr 2004;32(2):211-7. [Medline].

  48. Vogt A. Reflexlinien durch faltung spiegelnder grenzflachen im bereiche von corneo, linsenkapsel und netzhaut. Albrecht von Graefes Arch Ophthalmol. 1919;99:296-338.

  49. Wilson SE, Lin DT, Klyce SD. Corneal topography of keratoconus. Cornea. Jan 1991;10(1):2-8. [Medline].

  50. Wollensak G. Crosslinking treatment of progressive keratoconus: new hope. Curr Opin Ophthalmol. Aug 2006;17(4):356-60. [Medline].

  51. Zadnik K, Barr JT, Steger-May K, et al. Comparison of flat and steep rigid contact lens fitting methods in keratoconus. Optom Vis Sci. Dec 2005;82(12):1014-21. [Medline].

Previous
Next
 
An optic section of a keratoconic cornea shows corneal thinning. Vogt striae and some scarring can also be seen centrally; superiorly, a small (brown) section of the Fleischer ring is noted.
The fluorescein pattern of a rather flat-fitted rigid contact lens on an advanced keratoconic cornea.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.